DICYCLOPENTADIENE
General Information
Mainterm | DICYCLOPENTADIENE |
CAS Reg.No.(or other ID) | 77-73-6 |
Regnum |
177.2600 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 6492 |
IUPAC Name | |
InChI | InChI=1S/C10H12/c1-2-9-7-4-5-8(6-7)10(9)3-1/h1-2,4-5,7-10H,3,6H2 |
InChI Key | HECLRDQVFMWTQS-UHFFFAOYSA-N |
Canonical SMILES | C1C=CC2C1C3CC2C=C3 |
Molecular Formula | C10H12 |
Wikipedia | Dicyclopentadiene |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 132.206 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 0 |
Rotatable Bond Count | 0 |
Complexity | 212.0 |
CACTVS Substructure Key Fingerprint | A A A D c c B w A A A A A A A A A A A A A A A A A A A A A Y I E A A A g A A A A A A A Q A A A A A A A A G A A A A A A A D Q C A A A A A A A A A A A C A A C B C A A A A A A A g A A A I C A A A A A g A A A I A A Q A A A A A A g A A I A A M A g M A O g A A A A A A A A A A A A A A A A A A A A Q A A C A A A A A = = |
Topological Polar Surface Area | 0.0 |
Monoisotopic Mass | 132.094 |
Exact Mass | 132.094 |
XLogP3 | None |
XLogP3-AA | 2.5 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 10 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 4 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9749 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.6989 |
P-glycoprotein Substrate | Non-substrate | 0.8027 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9474 |
Non-inhibitor | 0.9077 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8445 |
Distribution | ||
Subcellular localization | Lysosome | 0.7353 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8544 |
CYP450 2D6 Substrate | Non-substrate | 0.8659 |
CYP450 3A4 Substrate | Non-substrate | 0.7797 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6463 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8945 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9397 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8436 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9104 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6514 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8785 |
Non-inhibitor | 0.9588 | |
AMES Toxicity | Non AMES toxic | 0.9133 |
Carcinogens | Non-carcinogens | 0.7430 |
Fish Toxicity | High FHMT | 0.9778 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9821 |
Honey Bee Toxicity | High HBT | 0.8695 |
Biodegradation | Not ready biodegradable | 0.9125 |
Acute Oral Toxicity | III | 0.7791 |
Carcinogenicity (Three-class) | Warning | 0.4795 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -4.0225 | LogS |
Caco-2 Permeability | 1.5465 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.5711 | LD50, mol/kg |
Fish Toxicity | -0.3253 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.3417 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Hydrocarbons |
Class | Polycyclic hydrocarbons |
Subclass | Not available |
Intermediate Tree Nodes | Not available |
Direct Parent | Polycyclic hydrocarbons |
Alternative Parents | |
Molecular Framework | Aliphatic homopolycyclic compounds |
Substituents | Polycyclic hydrocarbon - Cyclic olefin - Unsaturated aliphatic hydrocarbon - Unsaturated hydrocarbon - Olefin - Aliphatic homopolycyclic compound |
Description | This compound belongs to the class of organic compounds known as polycyclic hydrocarbons. These are polycyclic organic compounds made up only of carbon and hydrogen atoms. |
From ClassyFire